Geisinger MyCode Study Reveals Prevalence of Somatic Variants Linked to Rare Syndrome
Using exome sequence data for more than 163,000 Geisinger MyCode participants, researchers looked for variants in UBA1 that have been linked to VEXAS syndrome.
Novel Locus Tied to Rheumatic Heart Disease in Black Africans
A lack of an independent cohort limited the researchers' ability to replicate their finding and underscored the need for better representation of Africans in research.
Group A Streptococcus Vaccine Target Candidates Identified From Global Genome Set
Despite the diversity detected in Group A Streptococcus strains from more than 20 countries, investigators narrowed in on broadly shared sequences with relatively low variation.
The company said this week that is has raised $36 million in funding, as it continues efforts to develop its Maverick platform for rapid testing in doctors' offices.
People Transfer: Mar 18, 2009
Fate Therapeutics names Ken Batchelor CSO; SV Life Sciences' Ross and MedImmune Ventures' Amprey join NKT Therapeutics board